Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy

Frontiers in Oncology(2021)10.3389/fonc.2021.679331Source: DataRank Database

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (12)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Mary Jane Lim-Fat ORCID,Lei Qin ORCID,Angie Li ORCID,Annie G. Bryant ORCID,Camden Bay ORCID

Live enrichment

PubMed:34249718 PMC:PMC8268004

NCI NIH HHS

Grant: K12 CA090354

National Institutes of Health

Grant: 1R01LM012434-01

Computer aided diagnosis of cancer metastases in the brain

National Institutes of Health

Grant: 2K12CA090354-21

Training Program in Nervous System Tumors

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2021.679331/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2021.679331/full

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8268004

Europe_PMChttps://europepmc.org/articles/PMC8268004

Europe_PMChttps://europepmc.org/articles/PMC8268004?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

ImmunotherapyGlioblastomaMagnetic Resonance ImagingDisease ProgressionPseudoprogressionImmunotherapy Response Assessment For Neuro-OncologyResponse Assessment In Neuro-Oncology CriteriaOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

10.6084/m9.figshare.24431994.v1figshare

Additional file 1 of Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

10.6084/m9.figshare.24431994figshare

Additional file 2 of Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

10.6084/m9.figshare.24432110.v1figshare

Additional file 2 of Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

10.6084/m9.figshare.24432110figshare

Additional file 3 of Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

10.6084/m9.figshare.26631112.v1figshare

Additional file 3 of Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

10.6084/m9.figshare.26631112figshare